The 3D cell culture global market is poised to grow at a double digit CAGR to reach $1,485.1 million by 2024. Rise in Research and Development Investments, rising need for organ transplantation, Use of 3D cell culture models as an alternative tool for invivo testing, microfluidic technology and increasing focus on regenerative medicine are set to drive the market.
This report analyses the Chromatography global market by by Process type, Technology, Products, applications and geography. It also contain revenue forecast of the Chromatography global market and strategic analysis of each submarket with respect to segmental growth trends.
Biologics are therapeutic entities composed of sugars, proteins, or nucleic acids made from natural sources such as human, animal or micro organisms. Like small molecule drugs, these drugs are intended for treatment of diseases and medical conditions, these classes of drugs have proved to be highly beneficial for the patient and profits.
Animals in research are essential for the development of new and more effective methods for diagnosis and treatment of diseases and to mandatorily submit preclinical pharmacological, toxicological and pharmacokinetic findings. The animal studies are compared and extrapolated to determine relevant data for humans based on the animal species similarity to humans.
Cell lines are one of the major tools in pharmaceutical research and have wide range of applications in gene function studies, drug discovery assays, the production of biotherapeutics and diagnostics. Increasing demand for biologics and biosimilars has increased the demand for production cell lines.
The report covers all life instruments and associated reagents used in pharmaceuticals, biotechnology and diagnostics that help cutting edge research and innovative application. These technologies include from basic to advanced technologies, this report does not include medical devices or in-vitro diagnostics market; however the usage of instruments and reagents for diagnostic purpose is included in the market.
The cell analysis market is expected to grow steadily in the forecast period. Improved accuracy of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process is the major factor driving the market.
A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next Generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days.
Cell expansion process plays a key role in therapeutic development, drug screening and core research. It is used for improving the outcome of transplantation and diseases such as rheumatoid arthritis and diabetes. New technology such as 3D cell expansion technology is accelerating the growth of this market.
Over the last several decades, technologies for identification, isolation, sequencing, replication and integration of desired genes in target organisms have transformed tremendously, emergence of genome editing technology is set to bring a paradigm shift in gene modification approaches.